STADA Arzneimittel AG - Company Profile and SWOT Analysis

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $175	41 Pages	MarketLine	May, 2025	MTLN20137549

Best Price Guarantee
Price	from $175
Length	41 Pages
Publisher	MarketLine
Published Date	May, 2025
SKU	MTLN20137549

STADA Arzneimittel AG - Company Profile and SWOT Analysis

Summary

STADA Arzneimittel AG - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

STADA Arzneimittel AG (STADA), a subsidiary of Nidda Healthcare GmbH, specializes in the production of consumer healthcare, generics, and specialty pharmaceutical products. Its key offerings include medications for cough and cold, dermatological conditions, pain relief, vitamins, minerals, gastrointestinal issues, sleep aids, and health products for both women and men, bone health, immunology, nephrology, neurology, oncology, ophthalmology, and biosimilars. STADA distributes products from other pharmaceutical manufacturers. It serves a diverse customer base through various brands, including Nizoral, Zoflora, Grippostad, SNUP, Silomat, and Hirudoid, across Asia, the Middle East, and Europe. STADA is headquartered in Bad Vilbel, Hessen, Germany.

Scope

Detailed information on STADA Arzneimittel AG required for business and competitor intelligence needs
A study of the major internal and external factors affecting STADA Arzneimittel AG in the form of a SWOT analysis
An in-depth view of the business model of STADA Arzneimittel AG including a breakdown and examination of key business segments
Intelligence on STADA Arzneimittel AG's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about STADA Arzneimittel AG, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of STADA Arzneimittel AG and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess STADA Arzneimittel AG as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on STADA Arzneimittel AG's business structure, strategy and prospects.

Company Snapshot: STADA Arzneimittel AG: Company Overview; STADA Arzneimittel AG: Overview and Key Facts; STADA Arzneimittel AG: Overview; STADA Arzneimittel AG: Key Facts; STADA Arzneimittel AG: Key Employees; STADA Arzneimittel AG: Key Employee Biographies; STADA Arzneimittel AG: Major Products and Services; STADA Arzneimittel AG: Management Statement; STADA Arzneimittel AG: Locations and Subsidiaries; STADA Arzneimittel AG: Key Competitors; STADA Arzneimittel AG: Company Analysis; STADA Arzneimittel AG: Business Description; STADA Arzneimittel AG: SWOT Analysis; STADA Arzneimittel AG: SWOT Overview; STADA Arzneimittel AG: Strengths; STADA Arzneimittel AG: Weaknesses; STADA Arzneimittel AG: Opportunities; STADA Arzneimittel AG: Threats; STADA Arzneimittel AG: Corporate Financial Deals Activity; STADA Arzneimittel AG: Financial Deals Overview; STADA Arzneimittel AG: Targets and Partners; STADA Arzneimittel AG: Top Deals 2021 - 2025YTD*; STADA Arzneimittel AG: Advisors; STADA Arzneimittel AG: Top Legal Advisors; STADA Arzneimittel AG: Mergers and Acquisitions; STADA Arzneimittel AG: Capital Raising; STADA Arzneimittel AG: Partnership; STADA Arzneimittel AG: Recent Developments; STADA Arzneimittel AG: News and Events Summary; STADA Arzneimittel AG: Business Expansion; STADA Arzneimittel AG: Corporate Governance; STADA Arzneimittel AG: Financial Deals; STADA Arzneimittel AG: Financial Performance; STADA Arzneimittel AG: Regulatory and Legal Events; STADA Arzneimittel AG: Research & Development; STADA Arzneimittel AG: Strategy and Operations
Appendix: Contact Us; Methodology; About MarketLine
List of Tables: Table 1: STADA Arzneimittel AG: Key Facts; Table 2: STADA Arzneimittel AG: Key Employees; Table 3: STADA Arzneimittel AG: Locations and Subsidiaries; Table 4: STADA Arzneimittel AG: Key Competitors; Table 5: STADA Arzneimittel AG: Deal Activity by Deal Type - Volume (TTM*); Table 6: STADA Arzneimittel AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025); Table 7: STADA Arzneimittel AG: M&A Average Deal Size - Value (US$m); Table 8: STADA Arzneimittel AG: Targets and Partners; Table 9: STADA Arzneimittel AG: Top Deals 2021 - 2025YTD*; Table 10: STADA Arzneimittel AG: Legal Advisor Ranking by Value (US$m); Table 11: STADA Arzneimittel AG: M&A Volume and Value Trend (2021 - YTD*2025); Table 12: STADA Arzneimittel AG: Capital Raising Volume and Value Trend (2021 - YTD*2025); Table 13: STADA Arzneimittel AG: Capital Raising by Deal Type (2021 - YTD*2025); Table 14: STADA Arzneimittel AG: Partnership Volume and Value Trend (2021 - YTD*2025); Table 15: STADA Arzneimittel AG: Partnership Trend by Deal Type (2021 - YTD*2025); Table 16: STADA Arzneimittel AG: News and Events Summary; Table 17: STADA Arzneimittel AG: Business Expansion; Table 18: STADA Arzneimittel AG: Corporate Governance; Table 19: STADA Arzneimittel AG: Financial Deals; Table 20: STADA Arzneimittel AG: Financial Performance; Table 21: STADA Arzneimittel AG: Regulatory and Legal Events; Table 22: STADA Arzneimittel AG: Research & Development; Table 23: STADA Arzneimittel AG: Strategy and Operations
List of Figures: Figure 1: STADA Arzneimittel AG: Deal Activity by Deal Type - Volume (TTM*); Figure 2: STADA Arzneimittel AG: Deal Activity by Deal Type - Volume (2021 - YTD*2025); Figure 3: STADA Arzneimittel AG: M&A Average Deal Size - Value (US$m); Figure 4: STADA Arzneimittel AG: M&A Volume and Value Trend (2021 - YTD*2025); Figure 5: STADA Arzneimittel AG: Capital Raising Volume and Value Trend (2021 - YTD*2025); Figure 6: STADA Arzneimittel AG: Capital Raising by Deal Type (2021 - YTD*2025); Figure 7: STADA Arzneimittel AG: Partnership Volume and Value Trend (2021 - YTD*2025); Figure 8: STADA Arzneimittel AG: Partnership Trend by Deal Type (2021 - YTD*2025)